349 related articles for article (PubMed ID: 12664317)
21. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.
Romanò CL; Duci D; Romanò D; Mazza M; Meani E
J Arthroplasty; 2004 Jan; 19(1):14-8. PubMed ID: 14716644
[TBL] [Abstract][Full Text] [Related]
22. Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty.
Amstutz HC; Fowble VA; Schmalzried TP; Dorey FJ
J Arthroplasty; 1997 Feb; 12(2):126-32. PubMed ID: 9139094
[TBL] [Abstract][Full Text] [Related]
23. Postoperative nonsteroidal antiinflammatory drugs and the prevention of heterotopic ossification after cervical arthroplasty: analysis using CT and a minimum 2-year follow-up.
Tu TH; Wu JC; Huang WC; Chang HK; Ko CC; Fay LY; Wu CL; Cheng H
J Neurosurg Spine; 2015 May; 22(5):447-53. PubMed ID: 25723121
[TBL] [Abstract][Full Text] [Related]
24. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.
Pohl F; Seufert J; Tauscher A; Lehmann H; Springorum HW; Flentje M; Koelbl O
Strahlenther Onkol; 2005 Aug; 181(8):529-33. PubMed ID: 16044221
[TBL] [Abstract][Full Text] [Related]
25. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery.
Rath E; Warschawski Y; Maman E; Dolkart O; Sharfman ZT; Salai M; Amar E
Am J Sports Med; 2016 Mar; 44(3):677-81. PubMed ID: 26695395
[TBL] [Abstract][Full Text] [Related]
26. [External radiotherapy or non-steroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement].
Zouhair A; Ozsahin M; Mouhsine E; Leyvraz PF; Mirimanoff RO; Coucke PA
Schweiz Med Wochenschr; 1999 Mar; 129(9):370-6. PubMed ID: 10198948
[TBL] [Abstract][Full Text] [Related]
27. Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty.
van der Heide HJ; Koorevaar RT; Schreurs BW; van Kampen A; Lemmens A
J Arthroplasty; 1999 Oct; 14(7):796-9. PubMed ID: 10537252
[TBL] [Abstract][Full Text] [Related]
28. No effective prophylaxis of heterotopic ossification with short-term ibuprofen.
Koorevaar CT; Hu HP; Lemmens A; van Kampen A
Arch Orthop Trauma Surg; 1999; 119(3-4):183-5. PubMed ID: 10392515
[TBL] [Abstract][Full Text] [Related]
29. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.
Kjaersgaard-Andersen P; Schmidt SA
Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640
[TBL] [Abstract][Full Text] [Related]
30. Celecoxib and heterotopic bone formation after total hip arthroplasty.
Lavernia CJ; Contreras JS; Villa JM; Rossi MD
J Arthroplasty; 2014 Feb; 29(2):390-2. PubMed ID: 23927909
[TBL] [Abstract][Full Text] [Related]
31. Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review.
Haffer H; Müller M; Ascherl R; Perka C; Winkler T
Hip Int; 2022 Mar; 32(2):144-151. PubMed ID: 33272062
[TBL] [Abstract][Full Text] [Related]
32. [Incidence of anterior intertrochanteric ossifications after total hip arthroplasty--a retrospective long-term follow-up study].
Metzner G; Lindner B; Neumann D; Dorn U
Z Orthop Unfall; 2010 Mar; 148(2):174-9. PubMed ID: 20178081
[TBL] [Abstract][Full Text] [Related]
33. Stable bony integration with and without short-term indomethacin prophylaxis. A 5-year follow-up.
Trnka HJ; Zenz P; Zembsch A; Easley M; Ritschl P; Salzer M
Arch Orthop Trauma Surg; 1999; 119(7-8):456-60. PubMed ID: 10613239
[TBL] [Abstract][Full Text] [Related]
34. Incidence of heterotopic ossification and effects of various prophylactic methods after hip resurfacing.
Le Duff MJ; Takamura KB; Amstutz HC
Bull NYU Hosp Jt Dis; 2011; 69 Suppl 1():S36-41. PubMed ID: 22035483
[TBL] [Abstract][Full Text] [Related]
35. Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement results of a prospective study in 462 hips.
Koelbl O; Seufert J; Pohl F; Tauscher A; Lehmann H; Springorum HW; Flentje M
Strahlenther Onkol; 2003 Nov; 179(11):767-73. PubMed ID: 14605747
[TBL] [Abstract][Full Text] [Related]
36. Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.
Winkler S; Springorum HR; Vaitl T; Handel M; Barta S; Kehl V; Craiovan B; Grifka J
Int Orthop; 2016 Apr; 40(4):673-80. PubMed ID: 26728611
[TBL] [Abstract][Full Text] [Related]
37. Indomethacin versus radiation therapy for heterotopic ossification after hip arthroplasty.
D'Lima DD; Venn-Watson EJ; Tripuraneni P; Colwell CW
Orthopedics; 2001 Dec; 24(12):1139-43. PubMed ID: 11770090
[TBL] [Abstract][Full Text] [Related]
38. [Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials].
Xu BG; Xue DT; Wang XH; Yan SG
Zhongguo Gu Shang; 2014 Jul; 27(7):609-14. PubMed ID: 25338452
[TBL] [Abstract][Full Text] [Related]
39. Incidence of heterotopic ossification after surface and conventional total hip arthroplasty: a comparative study using anterolateral approach and indomethacin prophylaxis.
Regis D; Sandri A; Sambugaro E
Biomed Res Int; 2013; 2013():293528. PubMed ID: 23865045
[TBL] [Abstract][Full Text] [Related]
40. Surgical excision of heterotopic bone after hip surgery followed by oral indomethacin application: is there a clinical benefit for the patient?
Wick M; Müller EJ; Hahn MP; Muhr G
Arch Orthop Trauma Surg; 1999; 119(3-4):151-5. PubMed ID: 10392508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
